Rapid Diagnostic Kits Market for Indian Ocean Region Countries
Rapid
Diagnostic Kits Market for Indian Ocean Region Countries (France, India,
Australia, Indonesia, Singapore, Sri Lanka, Madagascar) by Product
(Professional, OTC), Platform (Immunoassay, Molecular), Application (Infectious
Diseases, Cardiac, Urinalysis, Cholesterol), End User (Hospital, Diagnostic
Lab) - Forecast to 2029’, published by Meticulous Research®, the rapid
diagnostics kits market for Indian Ocean region countries is expected to
register a CAGR of 1.6% from 2022 to 2029 to reach $1.75 billion by 2029.
Download free sample report here: https://www.meticulousresearch.com/download-sample-report/cp_id=5418?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=02-04-2024
Rapid Diagnostics Kits Market for Indian Ocean Region
Countries: Future Outlook
The Rapid Diagnostics Kits Market for Indian Ocean Region
Countries is segmented by Product (Professional Kits and OTC Kits), Platform
(Immunoassays, Molecular Detection Tests, and Other Rapid Diagnostic
Platforms), Application (Blood Glucose Testing, Cardiac Metabolism Testing,
Infectious Diseases Testing, Pregnancy & Fertility Testing, Hematology
Testing, Tumor/Cancer Markers Testing, Urinalysis, Cholesterol Testing, and
Other Tests), End User (Hospitals & Clinics, Diagnostic Laboratories, Home
Care/Self-testing, and Other End Users) and Geography (France, India,
Australia, Singapore, Indonesia, Madagascar, Mauritius, Réunion, Comoros,
Mayotte, and Seychelles). The study also evaluates industry competitors and
analyzes their key growth strategies in the market.
Based on product, in 2022, the professional kits segment
accounted for the larger share of the rapid diagnostic kits market in Indian
Ocean region countries. The large market share of this segment is attributed to
the higher preference for PoC testing, the high prevalence of chronic diseases,
and technological advancements in rapid diagnostics, supporting the high
adoption of professional kits. However, the OTC kits segment is expected to
register the fastest growth over the forecast period. OTC kits are generally
at-home testing kits used for fertility testing, blood glucose monitoring,
cholesterol testing, and infectious and chronic disease testing. With home
testing kits, patients can save time and money required for hospital/lab
visits, as these tests can be performed at home, and results can be shared with
physicians remotely. The growth of this segment can be attributed to the rising
demand for at-home testing, growing awareness about self-testing among the
general population, and the increasing prevalence of diseases that require
rapid and effective testing.
Based on platform, in 2022, the immunoassays segment
accounted for the largest share of the rapid diagnostic kits market in Indian
Ocean region countries. However, the molecular detection segment is expected to
register the fastest growth rate in the forecast period. PCR is crucial in
clinical testing, including DNA fingerprinting, detecting bacteria or viruses,
and diagnosing genetic disorders. The use of RT-PCR tests grew more than
five-fold during the COVID-19 pandemic compared to the pre-pandemic period due
to their higher reliability and accuracy. The increased popularity and
awareness of RT-PCR diagnostic tests in developing countries such as India,
Indonesia, and Singapore are mainly attributed to the high demand for RT-PCR
diagnostic kits for coronavirus infection diagnosis. This increased popularity
and awareness are expected to create significant growth opportunities for
companies offering RT-PCR rapid diagnostic kits in these countries.
Click here for top trending blog: https://meticulousblog.org/top-10-companies-in-rapid-diagnostics-kits-market-for-indian-ocean-region-countries/?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=2-04-2024
Based on application, in 2022, the infectious diseases
testing segment accounted for the largest share of the rapid diagnostic kits
market for Indian Ocean region countries. However, the tumor/cancer markers
testing segment is expected to show the fastest growth rate in the forecast
period. The burden of cancer is growing, exerting tremendous economic strain on
countries. Nearly 70% of cancer deaths occur in low- and middle-income
countries (source: WHO). The burden of cancer is large in India, Australia, Singapore,
Indonesia, Madagascar, Mauritius, Réunion, Comoros, Mayotte, and Seychelles;
for example, in 2020, India reported 1,324,413 new cancer cases and this number
is projected to reach 1,692,968 by 2030(source: GLOBOCAN). Furthermore, France
reported 467,965 new cancer cases and this number is projected to reach 530,863
by 2030 (source: GLOBOCAN). Early detection is very important in reducing
mortality, improving the chances of survival, and saving on treatment costs.
Various rapid diagnostic kits are used to detect cancer. It is estimated that
the demand for rapid diagnostic kits that support cancer testing will grow
significantly in the coming years.
Based on end user, in 2022, the hospitals & clinics
segment accounted for the largest share of the rapid diagnostic kits market for
Indian Ocean region countries. However, the home care/self-testing segment is
expected to show the fastest growth rate in the forecast period. The home
care/self-testing segment includes rapid diagnostic kits that can be directly
used by the patient or general population at home with some specific healthcare
needs. These kits are simple and easy to use and enable users to monitor
themselves. The increasing prevalence of chronic diseases (requiring long-term
care and frequent monitoring), growing awareness about home care, and the
increasing geriatric population are driving the demand for rapid diagnostics in
home settings.
Download request sample report here: https://www.meticulousresearch.com/request-sample-report/cp_id=5418?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=02-04-2024
Based on Geography, France accounted for the largest share
of the market in 2022. In France, the population aged 65 years and above is
rising rapidly. According to the Organisation for Economic Co-operation and
Development (OECD), the population aged 65 years and above in France is growing
at a rate of 2.0% annually. According to the Council of the European Union, in
2019, 63% of the total population aged 65 years and above had at least one
chronic disease. Thus, a high prevalence of chronic conditions among the
elderly coupled with high access to healthcare services are supporting the
largest share of this region.
Some of the key companies operating in the rapid diagnostic
kits market for Indian Ocean region countries are Abbott Laboratories (U.S.),
Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F.
Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc. (U.S.), Danaher
Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A.
(France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian
Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment